Patrick Lamy
CIK 1961273 · See Remarks · last filed 2025-12-09
Patrick Lamy is a corporate insider who has filed 17 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing, for AKRO, was dated Dec 9, 2025. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
17
-$1.46M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics, Inc. (AKRO) Delisted | See Remarks | 0 | $54.65 | $0 | -$1.46M | 17 | 2025-12-09 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) Delisted | Disp (D) | −29,891 | $0 | EDGAR |
| 2025-07-03 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −2,000 | -$105.8K | EDGAR |
| 2025-07-02 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | +193 | $4.6K | EDGAR |
| 2025-06-20 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −875 | -$47.8K | EDGAR |
| 2025-06-20 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$68.5K | EDGAR |
| 2025-06-12 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −919 | -$49.6K | EDGAR |
| 2025-06-04 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$121.8K | EDGAR |
| 2025-05-23 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$22.5K | EDGAR |
| 2025-05-09 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$181.0K | EDGAR |
| 2025-03-05 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$28.2K | EDGAR |